You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-SQSTM1 / p62 antibodySee all SQSTM1 / p62 primary antibodies ...
  • Description
    Sheep polyclonal to SQSTM1 / p62
  • Specificityab31545 recognises SQSTM1/p62 in normal and diseased human brain.
  • Tested applicationsIHC-P, IHC-Fr, WB more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide from part of human Ubiquitin Interactive Motif (UIM) derived from p62 protein, also known as SQSTM1. Amino acid sequence: PPEADPRLIE SLSQMLSMGF SDEGGWLTRL LQTKNYDIGA

  • Positive controlHuman brain homogenate

Properties

Applications

Our Abpromise guarantee covers the use of ab31545 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-P IHC-P: Use at an assay dependent dilution.
IHC-Fr IHC-Fr: 1/500 - 1/2000.
WB WB: Use at an assay dependent dilution. Detects a band of approximately 47, 50 kDa (predicted molecular weight: 47 kDa).

Target

  • FunctionAdapter protein which binds ubiquitin and may regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1. May play a role in titin/TTN downstream signaling in muscle cells. May regulate signaling cascades through ubiquitination. Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). May be involved in cell differentiation, apoptosis, immune response and regulation of K(+) channels.
  • Tissue specificityUbiquitously expressed.
  • Involvement in diseaseDefects in SQSTM1 are a cause of Paget disease of bone (PDB) [MIM:602080]. PDB is a metabolic bone disease affecting the axial skeleton and characterized by focal areas of increased and disorganized bone turn-over due to activated osteoclasts. Manifestations of the disease include bone pain, deformity, pathological fractures, deafness, neurological complications and increased risk of osteosarcoma. PDB is a chronic disease affecting 2 to 3% of the population above the age of 40 years.
  • Sequence similaritiesContains 1 OPR domain.
    Contains 1 UBA domain.
    Contains 1 ZZ-type zinc finger.
  • DomainThe UBA domain binds specifically 'Lys-63'-linked polyubiquitin chains of polyubiquitinated substrates. Mediates the interaction with TRIM55.
    The OPR domain mediates homooligomerization and interactions with PRKCZ, PRKCI, MAP2K5 and NBR1.
    The ZZ-type zinc finger mediates the interaction with RIPK1.
  • Post-translational
    modifications
    Phosphorylated. May be phosphorylated by PRKCZ (By similarity). Phosphorylated in vitro by TTN.
  • Cellular localizationCytoplasm. Late endosome. Nucleus. Sarcomere (By similarity). In cardiac muscles localizes to the sarcomeric band (By similarity). Localizes to late endosomes. May also localize to the nucleus. Accumulates in neurofibrillary tangles and in Lewy bodies of neurons from individuals with Alzheimer and Parkinson disease respectively. Enriched in Rosenthal fibers of pilocytic astrocytoma. In liver cells, accumulates in Mallory bodies associated with alcoholic hepatitis, Wilson disease, indian childhood cirrhosis and in hyaline bodies associated with hepatocellular carcinoma.
  • Target information above from: UniProt accession Q13501 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      A170 antibodyEBI 3 associated protein of 60 kDa antibodyEBI 3 associated protein p60 antibody
      EBI3 associated protein of 60 kDa antibodyEBI3 associated protein p60 antibodyEBI3-associated protein of 60 kDa antibodyEBIAP antibodyMGC127197 antibodyORCA antibodyOSF-6 antibodyOsi antibodyOSIL antibodyOxidative stress induced like antibodyp60 antibodyp62 antibodyp62B antibodyPaget disease of bone 3 antibodyPDB 3 antibodyPDB3 antibodyPhosphotyrosine independent ligand for the Lck SH2 domain of 62 kDa antibodyPhosphotyrosine independent ligand for the Lck SH2 domain p62 antibodyPhosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa antibodyPKC-zeta-interacting protein antibodyProtein kinase C-zeta-interacting protein antibodySequestosome 1 antibodySequestosome-1 antibodySQSTM 1 antibodySQSTM_HUMAN antibodySqstm1 antibodySTAP antibodySTONE14 antibodyUbiquitin binding protein p62 antibodyUbiquitin-binding protein p62 antibodyZIP 3 antibodyZIP antibodyZIP3 antibody
    see all

Anti-SQSTM1 / p62 antibody images

  • All lanes : Anti-SQSTM1 / p62 antibody (ab31545) at 1/500 dilution

    Lane 1 : A549 (Human lung adenocarcinoma epithelial cell line) Whole Cell Lysate
    Lane 2 : MCF7 (Human breast adenocarcinoma cell line) Whole Cell Lysate
    Lane 3 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    Rabbit polyclonal Secondary Antibody to Sheep IgG - H&L (HRP) at 1/3000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 47 kDa
    Observed band size : 47 + 50 kDa (why is the actual band size different from the predicted?)


    Exposure time : 30 seconds
  • ab31545 staining SQSTM1 / p62 in murine spinal cord sections by Immunohistochemistry (Frozen sections).

    Tissue was fixed in 4% paraformaldehyde, blocked with 10% goat serum for 2 hours at 25°C and then incubated with ab31545 at a 1/500 dilution for 18 hours at 4°C. The secondary used was an Alexa-Fluor 594 conjugated donkey anti-sheep (H+L) polyclonal used at a 1/1000 dilution.

    See Abreview

References for Anti-SQSTM1 / p62 antibody (ab31545)

This product has been referenced in:
  • Vanhorebeek I  et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab 96:E633-45 (2011). WB ; Human . Read more (PubMed: 21270330) »
  • Castillo K  et al. BAX inhibitor-1 regulates autophagy by controlling the IRE1a branch of the unfolded protein response. EMBO J : (2011). Read more (PubMed: 21926971) »

See all 2 Publications for this product

Product Wall

Displaying 1 - 4 of 4 results for Abreviews and Q&A

Application Immunohistochemistry (Frozen sections)
Sample Mouse Tissue sections (spinal cord)
Specification spinal cord
Fixative Paraformaldehyde
Permeabilization No
Blocking step Serum as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: 25°C
Username

Verified customer

Submitted Feb 04 2012

  Thank you for contacting us. Unfortunately, we don’t have specific data regarding the reactivity of this antibody in Drosophila. It has only been tested in mammalian species. Could you please specify the source where you found the reference to the react...

Read More
Application Western blot
Sample Fruit fly (Drosophila melanogaster) Cell lysate - whole cell (Kc cells)
Loading amount 1e+006 cells
Specification Kc cells
Treatment RNAi against indicated gene for three days
Gel Running Conditions Reduced Denaturing (8% Gel)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Jul 23 2010

Thank you for your enquiry. The synthetic peptide used to raise ab31545 was derived from part of human Ubiquitin Interactive Motif (UIM) derived from p62 protein, also known as SQSTM1. The amino acid sequence is as follows: PPEADPRLIE SLSQMLSMGF SDEGG...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"